Akebia Therapeutics Inc (AKBA)
EBITDA
-$5.18M
Quarterly · Period ending: · USD
AKBA EBITDA
Latest reported-$5.18Mperiod ending
Latest reported-$5.18Mperiod ending
AKBA Quarterly EBITDA (-$1.85M → -$5.18M)
Quarterly EBITDA
High-resolution chart · PNG
AKBA ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -5,182,000 | |
| -13,291,000 | |
| -6,087,000 | |
| 6,221,000 | |
| 7,397,000 | |
| 14,196,000 | |
| -6,582,000 | |
| -4,004,000 | |
| 1,185,000 | |
| -4,913,000 | |
| 11,436,000 | |
| -3,672,000 | |
| -123,000 | |
| -15,906,000 | |
| 17,196,000 | |
| -40,720,000 | |
| 43,912,000 | |
| -47,931,000 | |
| -47,963,000 | |
| -44,975,000 | |
| -68,567,000 | |
| -55,251,000 | |
| -47,497,000 | |
| -51,065,000 | |
| -163,822,000 | |
| -49,150,000 | |
| -65,221,000 | |
| -46,161,000 | |
| -49,315,000 | |
| -65,639,000 | |
| -86,675,000 | |
| -27,618,000 | |
| -35,448,000 | |
| -24,299,000 | |
| 11,564,000 | |
| -24,009,000 | |
| -22,018,000 | |
| -44,837,000 | |
| -37,920,000 | |
| -36,088,000 | |
| -36,142,000 | |
| -26,014,000 | |
| -20,039,000 | |
| -19,643,000 | |
| -10,858,000 | |
| -10,777,000 | |
| -10,191,000 | |
| -9,571,000 | |
| -7,828,000 | |
| -9,577,315 | |
| -2,730,329 | |
| -4,033,991 | |
| 0 | |
| -2,576,718 | |
| -1,854,084 |